Anbio Biotechnology
NASDAQ:NNNN
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| DE |
A
|
Anbio Biotechnology
NASDAQ:NNNN
|
3B USD |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
391.1B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.3B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
180.1B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.6B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.8B AUD |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
37.6B EUR |
Loading...
|
Market Distribution
| Min | -5 776.5% |
| 30th Percentile | 29.1% |
| Median | 44.6% |
| 70th Percentile | 60.9% |
| Max | 184.7% |
Other Profitability Ratios
Anbio Biotechnology
Glance View
Anbio Biotechnology is a DE-based company operating in Biotechnology industry. The company is headquartered in Frankfurt, Hessen. The company went IPO on 2025-02-19. Anbio Biotechnology is a Germany-based company. The firm is primarily engaged in the manufacturing of In Vitro Diagnostic Substance.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Anbio Biotechnology is 79.2%, which is above its 3-year median of 69.7%.
Over the last 1 years, Anbio Biotechnology’s Gross Margin has increased from 57.9% to 79.2%. During this period, it reached a low of 57.9% on May 30, 2024 and a high of 79.2% on Jul 30, 2025.
